Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment

In conclusion, the therapeutic use of phytocannabinoids (CBD) is already in practice, although its mechanisms of action remain unclear. Endocannabinoid and TRPV1 mechanisms warrant further basic studies to support their potential clinical applications.This article is part of the Special Issue “NEWroscience 2018".

Source: Epilepsy and Behavior - December 13, 2019 Category: Neurology Source Type: research